Disclosed herein are influenza vaccine compositions, related preparations and intermediates, formulations, production methods, immunization methods, and use thereof, for achieving improved immune-protection inhuman subjects. More specifically, non-egg-based influenza vaccines are described, which provide improved antigenic match.
